JEMO-PHARM A/S: Financial statements 2022
CVR: 10216109
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 10,078,000 and a net result of DKK -930,000 compared with DKK 166,000 the year before. That is a decrease of 12.5% compared with the year before. Equity in the 2022 report amounted to DKK -364,000. The company had 29 employees in the financial year.
- Gross Profit
- DKK 10,078,000
- Profit/Loss
- DKK -930,000
- Equity
- DKK -364,000
- Total Assets
- DKK 42,226,000
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 10.1 mio. | -930 t. | -364 t. | 29 |
| 2021 | - | 11.5 mio. | 166 t. | 566 t. | 28 |
| 2020 | - | 8.6 mio. | -2.8 mio. | 400 t. | 24 |
| 2019 | - | 5.9 mio. | -6.1 mio. | -3.5 mio. | 25 |
| 2018 | - | 9.8 mio. | 23 t. | 2.6 mio. | 20 |
Official annual report
Keep an eye on JEMO-PHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
JEMO-PHARM A/S has published its annual report for 2021. Gross profit came to DKK 11,517,000, and the net result was DKK 166,000.
About JEMO-PHARM A/S
JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named CMA TERADATA A/S and TERADATA A/S. The management consists of Mikael Andreas Mohr. The board consists of Svend Aage Dreist Hansen (chair), Henrik Winther Olsen and Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity in the 2025 report amounted to DKK 10,041,000.